UNSPSC 51144701: Flucetorex

This classification denotes an anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 0JJT8MQ49S. European Medicines Agency schedules Flucetorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07669MIG. Flucetorex generally arises in the molecular formula C20H21F3N2O3.

UNSPSC 51144701 Flucetorex, a Commodity code, does not map to the recent state and local solicitation activity tagged under it. The single recent opportunity on record is Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems—products unrelated to flucetorex, a pharmaceutical compound used in veterinary and human medicine contexts distinct from opioid-reversal agents or drug destruction equipment. The code shows no recent relevant activity supporting a procurement strategy under its nominal scope.

Seminole County Community Health issued IFB60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding. Responses were due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include shipping and delivery costs in their bids, maintain workers' compensation and commercial general liability coverage, comply with E-Verify requirements, and hold drug-free workplace certification. The initial contract term is two years with a one-year renewal option and a three-month probationary period. The procurement is potentially FEMA-funded and subject to federal environmental compliance requirements. No explicit set-aside designations were specified. Given the mismatch between the code's nominal scope and actual procurement content, firms should verify UNSPSC coding with Seminole County before pursuing related opportunities, or monitor this code for future activity bearing on flucetorex itself.